236 related articles for article (PubMed ID: 19782074)
81. Pharmacologic management of Alzheimer disease, Part II: Antioxidants, antihypertensives, and ergoloid derivatives.
Flynn BL; Ranno AE
Ann Pharmacother; 1999 Feb; 33(2):188-97. PubMed ID: 10084415
[TBL] [Abstract][Full Text] [Related]
82. ACE Inhibitors Improve Skeletal Muscle by Preserving Neuromuscular Junctions in Patients with Alzheimer's Disease.
Qaisar R; Karim A; Iqbal MS; Alkahtani SA; Ahmad F; Kamli H
J Alzheimers Dis; 2023; 94(2):641-650. PubMed ID: 37334602
[TBL] [Abstract][Full Text] [Related]
83. Utilizing Proteomic Approaches to Uncover the Neuroprotective Effects of ACE Inhibitors: Implications for Alzheimer's Disease Treatment.
Yang MH; Ho TC; Chang CC; Su YS; Yuan CH; Chuang KP; Tyan YC
Molecules; 2023 Aug; 28(16):. PubMed ID: 37630190
[TBL] [Abstract][Full Text] [Related]
84. Cognitive enhancers (Nootropics). Part 3: drugs interacting with targets other than receptors or enzymes. Disease-modifying drugs. Update 2014.
Froestl W; Pfeifer A; Muhs A
J Alzheimers Dis; 2014; 42(4):1079-149. PubMed ID: 25061058
[TBL] [Abstract][Full Text] [Related]
85. Repurposing Licensed Drugs for Use Against Alzheimer's Disease.
Norins LC
J Alzheimers Dis; 2021; 81(3):921-932. PubMed ID: 33843684
[TBL] [Abstract][Full Text] [Related]
86. Is a potential Alzheimer's therapy already in use for other conditions? Can medications for hypertension, diabetes and acne help with the symptoms?
Corbett A; Ballard C
Expert Opin Investig Drugs; 2013 Aug; 22(8):941-3. PubMed ID: 23808708
[TBL] [Abstract][Full Text] [Related]
87. Repurposing Antihypertensive Drugs for the Management of Alzheimer's Disease.
Law CSW; Yeong KY
Curr Med Chem; 2021; 28(9):1716-1730. PubMed ID: 32164502
[TBL] [Abstract][Full Text] [Related]
88. Roles of Brain Angiotensin II in Cognitive Function and Dementia.
Mogi M; Iwanami J; Horiuchi M
Int J Hypertens; 2012; 2012():169649. PubMed ID: 23304450
[TBL] [Abstract][Full Text] [Related]
89. Advances in the pharmacotherapy of Alzheimer's disease.
Soares JC; Gershon S
Eur Arch Psychiatry Clin Neurosci; 1994; 244(5):261-71. PubMed ID: 7893772
[TBL] [Abstract][Full Text] [Related]
90. Angiotensin (1-7) Expressing Probiotic as a Potential Treatment for Dementia.
Hernandez AR; Banerjee A; Carter CS; Buford TW
Front Aging; 2021 Mar; 2():. PubMed ID: 34901930
[TBL] [Abstract][Full Text] [Related]
91. The Role of the Renin-Angiotensin System in Amyloid Metabolism of Alzheimer's Disease.
Chou CL; Yeh HI
Acta Cardiol Sin; 2014 Mar; 30(2):114-8. PubMed ID: 27122777
[TBL] [Abstract][Full Text] [Related]
92. Elderly care. Shifting thinking about memory impairment.
McCormick WC; Abrass IB
Lancet; 1998 Dec 19-26; 352 Suppl 4():SIV6. PubMed ID: 9872153
[No Abstract] [Full Text] [Related]
93. Could Management of Blood Pressure Prevent Dementia in the elderly?
Mogi M
Clin Hypertens; 2019; 25():27. PubMed ID: 31867123
[TBL] [Abstract][Full Text] [Related]
94. Blood-Brain Barrier Crossing Renin-Angiotensin System Drugs: Considerations for Dementia and Cognitive Decline.
Glodzik L; Santisteban MM
Hypertension; 2021 Sep; 78(3):644-646. PubMed ID: 34379433
[No Abstract] [Full Text] [Related]
95. A Role for the Brain RAS in Alzheimer's and Parkinson's Diseases.
Wright JW; Kawas LH; Harding JW
Front Endocrinol (Lausanne); 2013 Oct; 4():158. PubMed ID: 24298267
[TBL] [Abstract][Full Text] [Related]
96. The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases.
Wright JW; Kawas LH; Harding JW
Prog Neurobiol; 2015 Feb; 125():26-46. PubMed ID: 25455861
[TBL] [Abstract][Full Text] [Related]
97. Associations of anti-hypertensive treatments with Alzheimer's disease, vascular dementia, and other dementias.
Davies NM; Kehoe PG; Ben-Shlomo Y; Martin RM
J Alzheimers Dis; 2011; 26(4):699-708. PubMed ID: 21709373
[TBL] [Abstract][Full Text] [Related]
98. Angiotensins in Alzheimer's disease - friend or foe?
Kehoe PG; Miners S; Love S
Trends Neurosci; 2009 Dec; 32(12):619-28. PubMed ID: 19796831
[TBL] [Abstract][Full Text] [Related]
99. Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease.
Kirouac L; Rajic AJ; Cribbs DH; Padmanabhan J
eNeuro; 2017; 4(2):. PubMed ID: 28374012
[TBL] [Abstract][Full Text] [Related]
100. Targeting Renin-Angiotensin System Against Alzheimer's Disease.
Gebre AK; Altaye BM; Atey TM; Tuem KB; Berhe DF
Front Pharmacol; 2018; 9():440. PubMed ID: 29760662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
